[Meige's syndrome].
Kimura
Motonori
M
Section of Psychiatry and Behavioral Science, Tokyo Medical and Dental University Graduate School.
Motohashi
Nobutaka
N
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D008538:Meige Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy
D014150:Antipsychotic Agents; D018680:Cholinergic Antagonists; D002998:Clonazepam; D019274:Botulinum Toxins, Type A; D003024:Clozapine